STAT Plus New study points to best way to assess which cancer patients immunotherapy will help

STAT Plus: New study points to best way to assess which cancer patients immunotherapy will help

11:00 EST 14 Jan 2019 | STAT

In the study’s main surprise, what counts as a high mutational burden differs markedly from one type of cancer to another.